SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel

FHS
March 17, 2025
11:36 am

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

Does hormone-modulating therapy for breast cancer treatment affect risk for Alzheimer disease and related dementias?

The association between hormone-modulating therapy (HMT) for breast cancer treatment and the risk of developing Alzheimer’s disease and related dementias.

July 19, 2024

Oncology biosimilar case studies: bevacizumab biosimilars – Pharmaceutical Technology

Source: GlobalData, Pharma Intelligence Center © GlobalData. F = Forecast values. Roche’s anti-VEGF monoclonal antibody Avastin (bevacizumab) is one of the most successful oncology drugs

July 26, 2023

Man stabbed to death in Denver, police investigating as homicide

A man was stabbed to death Friday night in Denver’s Central Business District and police are investigating it as a homicide. The post Man stabbed

August 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.